Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum

Neurochemical Research

Volumn 34, Issue 7, 2009, Pages 1299-1303

  Kabuto, Hideaki ^a   Amakawa, Masao ^a   Mankura, Mitsumasa ^b   Yamanushi, Tomoko T ^a   Mori, Akitane ^b  

^a KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

DHA ethyl ester; Dopamine; Lipid peroxidation; Parkinson disease

Indexed keywords

DIHYDROXYPHENYLACETIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID ETHYL ESTER; DOPAMINE; HOMOVANILLIC ACID; OXIDOPAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TISSUE LEVEL;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; DOCOSAHEXAENOIC ACIDS; DOPAMINE; HOMOVANILLIC ACID; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED ICR; NEOSTRIATUM; OXIDATIVE STRESS; OXIDOPAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA;

EID: 67349204018     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9909-0     Document Type: Article

References (26)

1. B Halliwell 2006 Oxidative stress and neurodegeneration: where are we now? J Neurochem 97 1634 1658 10.1111/j.1471-4159.2006.03907.x
2. RJ Tolwani MW Jakowec GM Petzinger 1999 Experimental models of Parkinson's disease: insights from many models Lab Anim Sci 49 363 371 (Pubitemid 29411753)
3. R Andrew DG Watson SA Best 1993 The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls Neurochem Res 18 1175 1177 10.1007/BF00978370
4. Y Glinka M Gassen MBH Youdim 1997 Mechanism of 6-hydroxydopamine neurotoxicity J Neural Transm Suppl 50 55 66 (Pubitemid 27055928)
5. R Kumar AK Agarwal PK Seth 1995 Free radical-generated neurotoxicity of 6-hydroxydopamine J Neurochem 64 1703 1707
6. L Lauritzen HS Hansen MH Jørgensen 2001 The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina Prog Lipid Res 40 1 94 10.1016/S0163-7827(00)00017-5
7. B Halliwell S Chirico 1993 Lipid peroxidation: its mechanisms, measurement, and significance Am J Clin Nutr 57 715S 725S (Pubitemid 23141198)
8. VR King WL Huang SC Dyall 2006 Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat J Neurosci 26 4672 4680 10.1523/JNEUROSCI.5539-05.2006
9. E Kishida M Yano M Kasahara 1998 Distinctive inhibitory activity of docosahexaenoic acid against sphingosin-induced apoptosis Biochim Biophys Acta 1391 401 408 (Pubitemid 28202136)
10. HY Kim M Akbar A Lau 2000 Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect J Biol Chem 275 35215 35223 10.1074/jbc.M004446200
11. S Florent C Malaplate-Armand I Youssef 2006 Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers J Neurochem 96 385 395 10.1111/j.1471-4159.2005.03541.x
12. JK Relton PJLM Strijbos AL Cooper 1993 Dietary n-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat Brain Res Bull 32 223 226 10.1016/0361-9230(93)90180-J
13. KA Youdim A Martin JA Joseph 2000 Essential fatty acids and the brain: possible health implications Int J Dev Neurosci 18 383 399 10.1016/S0736- 5748(00)00013-7
14. K Yamazaki T Hamazaki S Yano 1991 Changes in fatty acid composition in rat blood and organs after infusion of docosahexaenoic acid ethyl ester Am J Clin Nutr 53 620 627 (Pubitemid 21917632)
15. JA Buege SD Aust 1978 Microsomal lipid peroxidation Methods Enzymol 52 302 310 10.1016/S0076-6879(78)52032-6
16. OJ Lowry NJ Rosebrough AL Farr 1951 Protein measurement with folin-phenol reagent J Biol Chem 193 265 275
17. DT Dexter FR Wells AJ Lees 1989 Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease J Neurochem 52 1830 1836 10.1111/j.1471-4159.1989.tb07264.x
18. LM Ambani MH Van Woert S Murphy 1975 Brain peroxidase and catalase in Parkinson disease Arch Neurol 32 114 118
19. SJ Kish C Morito O Hornykiewicz 1985 Glutathion peroxidase activity in Parkinson's diseases Neurosci Lett 58 343 346 10.1016/0304-3940(85)90078-3
20. P Riederer E Sofic WD Rausch 1989 Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains J Neurochem 52 515 520 10.1111/j.1471-4159.1989.tb09150.x
21. CW Olanow 1993 A radical hypothesis for neurodegeneration Trends Neurosci 16 439 444 10.1016/0166-2236(93)90070-3
22. F Calon G Cole 2007 Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies Prostaglandins Leukot Essent Fat Acids 77 287 293 10.1016/j.plefa.2007.10.019
23. N Blondeau C Widmann M Lazdonski 2002 Polyunsaturated fatty acids induce ischemic and epileptic tolerance Neuroscience 209 231 241 10.1016/S0306-4522(01) 00473-0
24. X Wang X Zhao ZY Mao 2003 Concentrations of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures Neuroreport 14 2457 2461 10.1097/00001756-200312190-00033
25. B Halliwel 1992 Reactive oxygen species and the central nervous system J Neurochem 59 1609 1623 10.1111/j.1471-4159.1992.tb10990.x
26. A Brand S Gil E Yavin 2000 N-methyl bases of ethanolamine prevent apoptotic cell death induced by oxidative stress in cells of oligodendroglia origin J Neurochem 74 1596 1604 10.1046/j.1471-4159.2000.0741596.x